Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Shield Therapeutics Plc
November 2024 Investor Forum
21st Nov 2024
Custodian Property Income REIT plc
November 2024 Investor Forum
20th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
105: Finding the venture opportunity in the energy transition | Reuben Wilcock of Blackfinch Ventures
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Advanced Oncotherapy
Life Sciences
FLASH benefits from new US reimbursement
11 Nov 2019
Diurnal Group Plc
Life Sciences
Approaching a number of near-term milestones
05 Nov 2019
Stay up-to-date with the latest research
Sign up to our newsletter
Shield Therapeutics Plc
Life Sciences
More choice for clinicians and patients
30 Oct 2019
genedrive Plc
Life Sciences
Acceleration of news flow expected
28 Oct 2019
Oxford BioMedica
Life Sciences
Demanding second half
16 Oct 2019
Allergy Therapeutics plc
Life Sciences
Continuing to gain market share
26 Sep 2019
Shield Therapeutics Plc
Life Sciences
FDA approval ushers in a new era for Shield
02 Sep 2019
Advanced Oncotherapy
Life Sciences
Nearing the end-goal
By
Dr Martin Hall
08 Aug 2019
Shield Therapeutics Plc
Life Sciences
FDA approval opens door to major US opportunity
05 Aug 2019
Redx Pharma
Life Sciences
Pan-RAF agreement strengthens balance sheet
18 Jul 2019
genedrive Plc
Life Sciences
Hepatitis C market frustrations
18 Jul 2019
Prev
1
...
7
8
9
10
11
...
22
Next
